Document is current

Article History

Accepted: 8 April 2024

First Online: 21 May 2024

Declarations

:

: This work was funded by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Rahway, NJ, USA.

: Dominic Muston is an employee of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Rahway, NJ, USA.

: As reported elsewhere, the KEYNOTE-826 trial was designed by academic advisors and employees of the sponsor, Merck Sharp and Dohme. An external data and safety monitoring committee oversaw the trial, and periodically assessed safety and efficacy. The trial protocol and all amendments were approved by the appropriate ethics body at each participating center. All the patients provided written informed consent.

: Not applicable.

: Not applicable.

: Merck Sharp & Dohme LLC, a subsidiary of Merck & Co, Inc, Rahway, NJ (MSD), is committed to providing qualified scientific researchers access to anonymized data and clinical study reports from the company’s clinical trials to conduct legitimate scientific research. MSD is also obligated to protect the rights and privacy of trial participants and, as such, have a procedure in place for evaluating and fulfilling requests for sharing company clinical trial data with qualified external scientific researchers. The MSD data-sharing website (available at ) outlines the process and requirements for submitting a data request.

: The code for the R package <i>psm3mkv</i> developed for this manuscript is freely available on CRAN (Comprehensive R Archive Network) [].